Preventing ventilator-associated pneumonia non-pharmacologically

IF 27.1 1区医学 Q1 CRITICAL CARE MEDICINE

Intensive Care Medicine Pub Date : 2024-10-30 DOI:10.1007/s00134-024-07696-x

Manuel Krone, Christian Seeber, Peter Nydahl

引用次数: 0

Abstract

In critically ill, intubated patients on intensive care unit (ICU), ventilator-associated pneumonia (VAP) is a significant complication contributing to substantial mortality, morbidity, and prolonged stays, which in turn requires considerable financial and natural resources [1, 2]. Preventing VAP is therefore essential for improving patients’ safety and enhancing the outcomes’ cost-effectiveness and sustainability of healthcare [1].

Abstract Image

查看原文本刊更多论文

非药物预防呼吸机相关肺炎

在重症监护病房（ICU）插管的重症患者中，呼吸机相关肺炎（VAP）是一种重要的并发症，可导致大量死亡、发病和住院时间延长，进而需要大量的财政和自然资源[1, 2]。因此，预防 VAP 对改善患者安全、提高结果的成本效益和医疗保健的可持续性至关重要 [1]。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Intensive Care Medicine 医学-危重病医学

CiteScore

51.50

自引率

2.80%

发文量

326

审稿时长

1 months

期刊介绍： Intensive Care Medicine is the premier publication platform fostering the communication and exchange of cutting-edge research and ideas within the field of intensive care medicine on a comprehensive scale. Catering to professionals involved in intensive medical care, including intensivists, medical specialists, nurses, and other healthcare professionals, ICM stands as the official journal of The European Society of Intensive Care Medicine. ICM is dedicated to advancing the understanding and practice of intensive care medicine among professionals in Europe and beyond. The journal provides a robust platform for disseminating current research findings and innovative ideas in intensive care medicine. Content published in Intensive Care Medicine encompasses a wide range, including review articles, original research papers, letters, reviews, debates, and more.